Compare LMB & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LMB | IRMD |
|---|---|---|
| Founded | 1901 | 1992 |
| Country | United States | United States |
| Employees | 1400 | N/A |
| Industry | Engineering & Construction | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2014 | 2014 |
| Metric | LMB | IRMD |
|---|---|---|
| Price | $93.41 | $88.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $116.67 | $116.00 |
| AVG Volume (30 Days) | ★ 162.2K | 79.5K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.90% |
| EPS Growth | ★ 25.68 | 16.67 |
| EPS | ★ 3.23 | 1.75 |
| Revenue | ★ $646,804,000.00 | $83,814,000.00 |
| Revenue This Year | $15.96 | $12.38 |
| Revenue Next Year | $5.90 | $11.31 |
| P/E Ratio | ★ $29.91 | $50.85 |
| Revenue Growth | ★ 24.68 | 14.43 |
| 52 Week Low | $65.08 | $50.36 |
| 52 Week High | $154.04 | $107.90 |
| Indicator | LMB | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 57.51 | 33.74 |
| Support Level | $88.30 | $82.64 |
| Resistance Level | $101.04 | $105.87 |
| Average True Range (ATR) | 3.98 | 2.88 |
| MACD | 1.03 | -0.41 |
| Stochastic Oscillator | 55.66 | 19.33 |
Limbach Holdings Inc is a building systems solutions firm that designs, delivers, and maintains mechanical (heating, ventilation, and air conditioning), electrical, plumbing, and controls (MEPC) systems. The Company partners with owners and operators of facilities across healthcare, industrial and manufacturing, data centers, life sciences, higher education, and cultural and entertainment markets. It operates through two segments: Owner Direct Relationships (ODR), which generates maximum revenue and includes owner direct projects, maintenance, and service on MEPC systems; and General Contractor Relationships (GCR), which manages new construction or renovation projects involving MEPC systems awarded by general contractors or construction managers.
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.